Shopping Cart 0
Cart Subtotal
AED 0

ArQule Inc (ARQL) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 1376
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

ArQule Inc (ARQL)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

ArQule Inc (ArQule) is a development stage clinical biotechnology company. It carries out discovery and development of next-generation, small molecule therapeutics for the treatment of various types of cancer. ArQule develops its oncology product candidates through novel approaches including activated checkpoint therapy platform and c-met survival protein platform. Its lead product candidate, ARQ 197 (tivantinib), an inhibitor of the c-Met receptor tyrosine kinase, is undergoing clinical-stage development. The other product pipeline of the company includes ARQ 087 is a multi-kinase inhibitor, ARQ 092 is an Akt inhibitor, ARQ 751 is a next-generation inhibitor of Akt, ARQ 761 is an activator of the damage response pathway, ARQ 531 is a B-cell malignancies and ARQ 087 is an inhibitor of fibroblast growth factor receptor. ArQule is headquartered in Burlington, Massachusetts, the US.

ArQule Inc Key Recent Developments

May 24,2018: ArQule Announces Two Key Appointments

May 07,2018: ArQule Reports First Quarter 2018 Financial Results

Nov 09,2017: ArQule Reports Third Quarter 2017 Financial Results

Aug 04,2017: ArQule Reports Second Quarter 2017 Financial Results

May 03,2017: Arqule Reports First Quarter 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

ArQule Inc-Key Facts 5

ArQule Inc-Key Employees 6

ArQule Inc-Key Employee Biographies 7

ArQule Inc-Major Products and Services 8

ArQule Inc-History 9

ArQule Inc-Company Statement 11

ArQule Inc-Locations And Subsidiaries 12

Head Office 12

Section 2-Company Analysis 13

Company Overview 13

ArQule Inc-Business Description 14

ArQule Inc-SWOT Analysis 15

SWOT Analysis-Overview 15

ArQule Inc-Strengths 15

ArQule Inc-Weaknesses 16

ArQule Inc-Opportunities 17

ArQule Inc-Threats 18

ArQule Inc-Key Competitors 19

Section 3-Company Financial Ratios 20

Financial Ratios-Capital Market Ratios 20

Financial Ratios-Annual Ratios 21

Performance Chart 23

Financial Performance 23

Financial Ratios-Interim Ratios 24

Financial Ratios-Ratio Charts 25

Section 4-Company's Lifesciences Financial Deals and Alliances 26

ArQule Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26

ArQule Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27

ArQule Inc, Recent Deals Summary 28

Section 5-Company's Recent Developments 29

May 07, 2018: ArQule Reports First Quarter 2018 Financial Results 29

Nov 09, 2017: ArQule Reports Third Quarter 2017 Financial Results 31

Aug 04, 2017: ArQule Reports Second Quarter 2017 Financial Results 33

May 03, 2017: Arqule Reports First Quarter 2017 Financial Results 34

Mar 07, 2017: ArQule Reports Fourth Quarter and Full Year 2016 Financial Results 35

Section 6-Appendix 37

Methodology 37

Ratio Definitions 37

About GlobalData 41

Contact Us 41

Disclaimer 41


List Of Figure

List of Figures

ArQule Inc, Performance Chart (2013-2017) 23

ArQule Inc, Ratio Charts 25

ArQule Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26

ArQule Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 27


List Of Table

List of Tables

ArQule Inc, Key Facts 5

ArQule Inc, Key Employees 6

ArQule Inc, Key Employee Biographies 7

ArQule Inc, Major Products and Services 8

ArQule Inc, History 9

ArQule Inc, Key Competitors 19

ArQule Inc, Ratios based on current share price 20

ArQule Inc, Annual Ratios 21

ArQule Inc, Annual Ratios (Cont...1) 22

ArQule Inc, Interim Ratios 24

ArQule Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26

ArQule Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27

ArQule Inc, Recent Deals Summary 28

Currency Codes 37

Capital Market Ratios 37

Equity Ratios 38

Profitability Ratios 38

Cost Ratios 39

Liquidity Ratios 39

Leverage Ratios 40

Efficiency Ratios 40

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

ArQule Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

GlaxoSmithKline LLC

Eagle Pharmaceuticals Inc

Deciphera Pharmaceuticals LLC

Cytokinetics Inc

Curis Inc

CTI BioPharma Corp

Compugen Ltd

Bristol-Myers Squibb Co

AVEO Pharmaceuticals Inc

Array BioPharma Inc

Ariad Pharmaceuticals Inc